Genetic variants in BCL‐2 family genes influence the risk of non‐syndromic cleft lip with or without cleft palate

Abstract

AbstractBackgroundThe BCL‐2 family is crucial for cell death regulation and is involved in development, tissue homeostasis, and immunity. This study aimed to investigate the association between genetic variants in BCL‐2 family genes and non‐syndromic cleft lip with or without cleft palate (NSCL/P) risk.MethodsA two‐stage case–control study was conducted in this association study. Gene‐based analysis using Multi‐marker Analysis of GenoMic Annotation was performed in the first stage cohort, which included 565 cases and 1269 controls. A logistic regression model was employed to assess the effect of single nucleotide polymorphisms (SNPs) on susceptibility to NSCL/P. Candidate SNPs were replicated by extra dbGaP case‐parent trios. Haploreg, RegulomeDB, and UCSC Genome Browser were used to identify enhancer effects of promising SNPs. Bulk RNA sequencing data obtained from the Gene Expression Omnibus was used to identify co‐expressed genes. Single‐cell RNA sequencing dataset was used to infer the cell population of the candidate gene. The “Monocle” package was used to analyze the pseudotime cell trajectories.ResultsRs3943258 located in the enhancer region was associated with the risk of NSCL/P (Pmeta = 5.66 × 10−04) and exhibited an eQTL effect for BCL2 (P = 3.96 × 10−02). Co‐expression and pathway enrichment analysis revealed that genes related to Bcl2 were significantly enriched in the PI3K‐Akt signaling pathway, MAPK signaling pathway, and Wnt signaling pathway. Five cell clusters were identified in single‐cell RNA sequencing, and Bcl2 was mainly located in the mesenchyme.ConclusionThe rs3943258 located within BCL2 was probably related to NSCL/P susceptibility.